GTHP (Guided Therapeutics) Total Liabilities: $6.78 Mil (As of Mar. 2026)


GTHP Guided Therapeutics Inc GTHP
18 GF Score
Price $0.20
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Total Liabilities?

Guided Therapeutics GTHP -16.63% 18 Total Liabilities is $6.78 Mil as of Mar. 2026. GuruFocus rates GTHP with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

Guided Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 was $6.78 Mil.

Guided Therapeutics's quarterly Total Liabilities increased from Sep. 2025 ($6.55 Mil) to Dec. 2025 ($7.33 Mil) but then declined from Dec. 2025 ($7.33 Mil) to Mar. 2026 ($6.78 Mil).

Guided Therapeutics's annual Total Liabilities increased from Dec. 2023 ($5.48 Mil) to Dec. 2024 ($6.27 Mil) and increased from Dec. 2024 ($6.27 Mil) to Dec. 2025 ($7.33 Mil).


Guided Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Total Liabilities Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.49 6.25 5.48 6.27 7.33

Guided Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.41 6.55 7.33 6.78
GTHP
18GF Score
Guided Therapeutics Inc GTHP
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Guided Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.324--6.006
=7.33

Guided Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.962+(0.818+5.5511151231258E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=6.78

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1.604--5.176
=6.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $6.78 Mil mean?
Guided Therapeutics (GTHP) has a Total Liabilities of $6.78 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Guided Therapeutics and its competitors.
Is Guided Therapeutics' Total Liabilities too high?
Guided Therapeutics' current Total Liabilities is $6.78 Mil. Overall, Guided Therapeutics has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' Total Liabilities compare to CTSO and IRIX?
Guided Therapeutics' Total Liabilities of $6.78 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Guided Therapeutics and its competitors. Guided Therapeutics's current Total Liabilities is $6.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Guided Therapeutics (GTHP) has a current Total Liabilities of $6.78 Mil. The current Total Liabilities is $6.78 Mil. Guided Therapeutics' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current Total Liabilities is $6.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
18GF Score

Get the complete analysis for GTHP

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price